The Brutalist Report

MarketWatch

• : Ardelyx wins long battle for FDA approval of kidney-disease treatment [949d]
• Dow Jones Newswires: Impact Biomedical files for IPO [949d]
• The Ratings Game: ‘Unprecedented’ AI server buildout may be happening too quickly, this analyst warns [949d]
• Therese Poletti's Tech Tales: AI stole the show this year, but earnings will drag Wall Street back to reality [949d]
• Earnings Results: United Airlines’ stock falls after bleak outlook for end of the year [949d]
• Earnings Results: J.B. Hunt stock falls as results miss expectations, amid continued lower shipping demand [949d]
• Market Extra: Why Biden’s planned Israel visit is calming markets — for now [949d]
• Banking: U.S. Bancorp’s stock rallies on release of Fed banking requirement [949d]
• Market Extra: ‘Bond math’ shows traders bold enough to bet on Treasurys could reap dazzling returns with little risk [949d]
• : 5 charts that show how the housing market crashed and burned in 18 months [949d]
• : Shares of bankrupt Rite Aid plunge despite meme-stock chatter [949d]
• : Lucid’s stock dives toward a record low after EV production data disappoints [949d]
• The Ratings Game: Dollar Tree’s stock has tumbled this year. Its millions of wealthier new customers could change that, analysts say. [949d]
• TaxWatch: If you live in these 13 states, the IRS could do your taxes next year — for free [949d]
• The Tell: Bonds looks ‘cheap’ to top JPMorgan strategist getting defensive amid Israel-Hamas war [949d]
• : The U.S. retirement system has some ‘major shortcomings,’ one report says. Artificial intelligence could help. [949d]
• The Tell: Long-term U.S. Treasury yields may resume their march higher despite recent bond-market swings, BlackRock says [949d]
• : GM delays Orion EV plant by one year to ‘better manage’ investment and EV demand [949d]
• : Overwhelmed by Medicare Advantage ads? You’re not alone, but change may be coming. [949d]
• : House speaker election: Jim Jordan comes up short in first round of voting [949d]